We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




RNAi Engineering May Prevent Mad Cow

By Biotechdaily staff writers
Posted on 31 Mar 2006
By "knocking down” the expression of disease-causing genes in a cloned goat fetus, researchers may have developed a way to prevent bovine spongiform encephalopathy (BSE), known as mad cow disease. More...


The researchers used genetic engineering to produce a goat cell line in which the gene encoding for prion protein (PrP) was targeted for silencing by RNA interference (RNAi). Cells from this line were then used for nuclear transfer to produce a transgenic goat fetus that showed a greater than 90% knock-down of PrP. In earlier studies, silencing the PrP gene in mice made them resistant to prion-mediated diseases, such as BSE. The results of the new research were published in the March 22 issue of the Proceedings of the [U.S.] National Academy of Sciences.

The same technology may be able to be used in cattle to prevent mad cow and other serious diseases, according to the researcher team, whose members are from Texas A&M's College of Veterinary Medicine & Biomedical Sciences (College Station, TX, USA) and the Howard Hughes Medical Institute's Cold Spring Harbor Laboratory (Cold Spring Harbor, NY, USA).

BSE is a fatal brain-wasting disease, first identified in 1986. It affects a cow's nervous system and causes the animal to lose much of its movement before it eventually dies. More than 180,000 cases of BSE have been confirmed worldwide, including recent cases in the United States. The disease can be passed to humans, and more than 100 such cases have been confirmed, most of those in the United Kingdom.

"The next step is to try and avoid the cloning process--to skip that process if possible in developing the disease-resistant animals,” explained Dr. Mark Westhusin, one of the researchers. "That's where more research is going to be needed and where the process goes from here.” Dr. Westhusin has been involved in several cloning "firsts,” including the cloning of a cat in 2002 and a white-tailed deer in 2004.



Related Links:
Texas A&M
HH Medical Institute's Cold Spring Harbor

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.